Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania

Share Article

The Firm is representing Risperdal lawsuit plaintiffs in the Pennsylvania litigation, and the results of the proceeding’s bellwether trials could provide insight into how other juries might rule in similar gynecomastia cases.

Free Case Review
Our Firm is representing a number of Risperdal lawsuit plaintiffs in the Pennsylvania litigation, all of whom allegedly experienced excessive male breast growth due to treatment with this medication.

Hundreds of Risperdal lawsuits (http://www.risperdallawsuit2014.com/) filed on behalf of individuals who allegedly suffered gynecomastia (male breast growth) and other complications related to the use of the antipsychotic drug continue to move forward in a mass tort litigation currently underway in Pennsylvania’s Philadelphia Court of Common Pleas. According to court documents, the litigation is proceeding with its bellwether trial program, as the third trial involving Risperdal’s alleged association with gynecomastia is scheduled to get underway today. (Case No. 1303-01812)

“Our Firm is representing a number of Risperdal lawsuit plaintiffs in the Pennsylvania litigation, all of whom allegedly experienced excessive male breast growth due to treatment with this medication. We will be monitoring the progress of this third bellwether trial closely, as its outcome may provide valuable insight into how other juries could rule in similar gynecomastia cases,” said Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to provide Risperdal lawsuit consultations to men and boys who allegedly developed gynecomastia due to their use of the medication.

Risperdal Litigation
Court documents indicate that just over 1,320 Risperdal lawsuits have been filed in the Pennsylvania mass tort program, all of which accuse Johnson & Johnson and its Janssen Pharmaceuticals unit of failing to adequately warn patients and doctors about the medication’s association with gynecomastia and other serious complications. The companies are also accused of intentionally concealing research that revealed Risperdal’s potential to increase the body’s production of prolactin, a hormone which plays a role in female breast development. Plaintiffs point out that excessive levels of prolactin have also been linked to the development of gynecomastia in men and boys. (In Re: Risperdal Litigation, Case Number 100300296)

According to court records, the Pennsylvania litigation concluded its first two bellwether trials involving Risperdal and gynecomastia earlier this year. The first trial ended on February 24th, with the jury awarding $2.5 million to an autistic man who experienced excessive breast growth after taking Risperdal as a child. (Case No. A-196444). The second trial concluded on March 20th, with the jury finding that Johnson & Johnson and Janssen’s warnings about male breast growth were inadequate. However, the plaintiff was not awarded any monetary damages because the panel concluded that he had not proven that Risperdal caused his condition. (Case No. 130301803)

Risperdal patients who allegedly developed gynecomastia connected with its use may be eligible to file their own lawsuit. To learn more about the ongoing Risperdal litigation, please contact Bernstein Liebhard LLP for a free case review by visiting the Firm’s website, or by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
info (at) consumerinjurylawyers (dot) com
http://www.risperdallawsuit2014.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website